
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1064 | 1051 | 1083 | 1109 | 1357 | 2340 |
Fund Return | 6.43% | 5.11% | 8.32% | 3.51% | 6.3% | 8.87% |
Place in category | 1722 | 1209 | 1316 | 1493 | 947 | 66 |
% in Category | 80 | 57 | 65 | 82 | 63 | 5 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
MFSM Global Equity Fund I1 GBP | 2.54B | 7.42 | 2.16 | 9.60 | ||
MFSM Global Equity Fund W1 GBP | 2.54B | 7.21 | 1.92 | 9.26 | ||
MFSM European Value Fund W1 GBP | 2.35B | 1.08 | -0.67 | 8.43 | ||
MFSM Prudent Wealth Fund I1 GBP | 2.09B | 4.83 | 4.84 | 8.04 | ||
MFSM US Value Fund I1 GBP | 1.97B | 13.30 | 6.26 | 10.29 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Wellington Strategic European EquNG | 3.81B | 13.54 | 10.28 | 10.42 | ||
GS S GS Europe CORE Equity Portfolg | 3.31B | 7.10 | 9.80 | 9.43 | ||
JPEurope Equity Plus Fund A perf dg | 2.64B | 7.58 | 10.10 | 8.22 | ||
MFSM European Value Fund W1 GBP | 2.35B | 1.08 | -0.67 | 8.43 | ||
Place Growth European Progress Inc | 874.69M | 6.88 | 6.15 | 6.10 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Nestle | CH0038863350 | 3.37 | 89.70 | +1.24% | |
ASML Holding | NL0010273215 | 3.03 | 668.60 | -3.14% | |
Richemont | CH0210483332 | 2.96 | 181.75 | -1.68% | |
Novo Nordisk B | DK0062498333 | 2.78 | 635.5 | -0.56% | |
Sanofi | FR0000120578 | 2.78 | 108.44 | +0.71% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review